PRPH ProPhase Labs, Inc.

Nasdaq prophaselabs.com


$ 0.19 $ -0.05 (-20.34 %)    

Thursday, 20-Nov-2025 14:13:17 EST
QQQ $ 588.39 $ -23.21 (-3.79 %)
DIA $ 458.82 $ -7.86 (-1.68 %)
SPY $ 654.93 $ -17.97 (-2.67 %)
TLT $ 89.26 $ 0.28 (0.31 %)
GLD $ 374.23 $ -0.95 (-0.25 %)
$ 0.2335
$ 0.23
$ 0.19 x 1,600
$ 0.19 x 1,600
$ 0.18 - $ 0.23
$ 0.22 - $ 0.93
1,535,899
na
10.78M
$ 0.94
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-19-2025 09-30-2025 10-Q
2 08-13-2025 06-30-2025 10-Q
3 05-20-2025 03-31-2025 10-Q
4 03-31-2025 12-31-2024 10-K
5 11-13-2024 09-30-2024 10-Q
6 08-14-2024 06-30-2024 10-Q
7 05-10-2024 03-31-2024 10-Q
8 03-28-2024 12-31-2023 10-K
9 11-13-2023 09-30-2023 10-Q
10 08-11-2023 06-30-2023 10-Q
11 05-12-2023 03-31-2023 10-Q
12 03-29-2023 12-31-2022 10-K
13 11-10-2022 09-30-2022 10-Q
14 08-12-2022 06-30-2022 10-Q
15 05-13-2022 03-31-2022 10-Q
16 03-31-2022 12-31-2021 10-K
17 11-12-2021 09-30-2021 10-Q
18 08-13-2021 06-30-2021 10-Q
19 05-14-2021 03-31-2021 10-Q
20 03-31-2021 12-31-2020 10-K
21 11-19-2020 09-30-2020 10-Q
22 08-11-2020 06-30-2020 10-Q
23 05-12-2020 03-31-2020 10-Q
24 03-26-2020 12-31-2019 10-K
25 11-12-2019 09-30-2019 10-Q
26 08-12-2019 06-30-2019 10-Q
27 05-14-2019 03-31-2019 10-Q
28 03-26-2019 12-31-2018 10-K
29 11-14-2018 09-30-2018 10-Q
30 08-20-2018 06-30-2018 10-Q
31 05-15-2018 03-31-2018 10-Q
32 03-28-2018 12-31-2017 10-K
33 11-13-2017 09-30-2017 10-Q
34 08-11-2017 06-30-2017 10-Q
35 05-15-2017 03-31-2017 10-Q
36 02-24-2017 12-31-2016 10-K
37 11-15-2016 09-30-2016 10-Q
38 08-11-2016 06-30-2016 10-Q
39 05-13-2016 03-31-2016 10-Q
40 03-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 prophase-labs-is-in-discussions-for-strategic-initiative-to-realize-significant-underlying-value-in-the-company-announced-it-is-in-ma-related-discussions-not-connected-to-a-crypto-treasury-strategy

ProPhase Labs in discussions for strategic initiative to realize significant underlying value in the Company. Voting for Curren...

 prophase-labs-q3-eps-016-misses-011-estimate-sales-883000k-miss-5690m-estimate

ProPhase Labs (NASDAQ:PRPH) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.1...

 prophase-labs-announces-publication-of-peer-reviewed-study-in-clinical-and-translational-gastroenterology-conducted-with-the-mayo-clinic-showing-100-sensitivity-and-strong-predictive-accuracy-for-progression-to-esophageal-cancer

Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for E...

 prophase-labs-entered-into-sales-agreement-with-westpark-capital-relating-to-shares-of-common-stock-offered-by-prospectus-supplement--may-offer-and-sell-shares-of-common-stock-from-time-to-time-up-to-43m

https://www.sec.gov/Archives/edgar/data/868278/000149315225018187/form424b5.htm

 prophase-labs-shareholders-approve-strategic-expansion-including-increase-in-authorized-shares-to-1b

ProPhase Labs Stockholders Deliver Strong Mandate at Special MeetingUNIONDALE, NY, Sept. 12, 2025 (GLOBE NEWSWIRE) -- ProPhase ...

 prophase-labs-q2-eps-011-beats-015-estimate-sales-1247m-may-not-be-comparable-to-3550m-estimate

The Company did not generate any revenues from diagnostic services for the three months ended June 30, 2025 and 2024, respectiv...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION